Enantioselective synthesis of orthogonally protected (2R,3R)-(-)- epicatechin derivatives, key intermediates in the de novo chemical synthesis of (-)-epicatechin glucuronides and sulfates

Tetrahedron Asymmetry

Volumn 24, Issue 7, 2013, Pages 362-373

  Zhang, Mingbao ^a   Erik Jagdmann, G ^a   Van Zandt, Michael ^a   Beckett, Paul ^a   Schroeter, Hagen ^b  

^a Institutes for Pharmaceutical Discovery   (United States)

^b MARS Symbioscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPICATECHIN; EPICATECHIN GLUCURONIDE; EPICATECHIN SULFATE; GLUCURONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; ENANTIOSELECTIVITY; PRIORITY JOURNAL; SYNTHESIS;

EID: 84876038177     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2013.02.012     Document Type: Article

References (43)

1. L.J. Porter Flavans and Proanthocyanidins J.B. Harborne, The Flavonoids, Advances in Research Since 1986 1994 Chapman & Hall London 23 56
2. S. Ellinger, A. Reusch, P. Stehle, and H.P. Helfrich Am. J. Clin. Nutr. 95 2012 1365
3. L. Hooper, C. Kay, A. Abdelhamid, P.A. Kroon, J.S. Cohn, E.B. Rimm, and A. Cassidy Am. J. Clin. Nutr. 95 2012 740
4. H. Schroeter, C. Heiss, J.P. Spencer, C.L. Keen, J.R. Lupton, and H.H. Schmitz Mol. Aspects Med. 31 2010 546
5. H. Van Praag, M.J. Lucero, G.W. Yeo, K. Stecker, N. Heivand, C. Zhao, E. Yip, M. Afanador, H. Schroeter, J. Hammerstone, and F.H. Gage J. Neurosci. 27 2007 5869
6. C. Heiss, S. Jahn, M. Taylor, W.M. Real, F.S. Angeli, M.L. Wong, N. Amabile, M. Prasad, T. Rassaf, J.I. Ottaviani, S. Mihardja, C.L. Keen, M.L. Springer, A. Boyle, W. Grossman, S.A. Glantz, H. Schroeter, and Y. Yeghiazarians J. Am. Coll. Cardiol. 56 2010 218
7. P.J. Curtis, M. Sampson, J. Potter, K. Dhatariya, P.A. Kroon, and A. Cassidy Diabetes Care 35 2012 226
8. H. Schroeter, C. Heiss, J. Balzer, P. Kleinbongard, C.L. Keen, N.K. Hollenberg, H. Sies, C. Kwik-Uribe, H.H. Schmitz, and M. Kelm Proc. Natl. Acad. Sci. U.S.A. 103 2006 1024
9. P.J. Mink, C.G. Scrafford, L.M. Barraj, L. Harnack, C.P. Hong, J.A. Nettleton, and D.R. Jacobs Jr. Am. J. Clin. Nutr. 85 2007 895
10. J.I. Ottovani, T.Y. Momma, G.K. Kuhnle, C.L. Keen, and H. Schroeter Free Radic. Biol. Med. 52 2012 1403
11. J.I. Ottaviani, C. Kwik-Uribe, C.L. Keen, and H. Schroeter Am. J. Clin. Nutr. 95 2012 851
12. J.I. Ottaviani, T.Y. Momma, C. Heiss, C. Kwik-Uribe, H. Schroeter, and C.L. Keen Free Radic. Biol. Med. 50 2011 237
13. M. Natsume, N. Osakabe, M. Oyama, M. Sasaki, S. Baba, Y. Nakamura, T. Osawa, and J. Terao Free Radic. Biol. Med. 34 2003 840
14. C. Auger, W. Mullen, Y. Hara, and A. Crozier J. Nutr. 2008 1535S
15. W. Mullen, G. Borges, J.L. Donovan, C.A. Edwards, M. Serafini, M.E.J. Lean, and A. Crozier Am. J. Clin. Nutr. 89 2009 1784
16. G. Kuhnle, J.P. Spencer, H. Schroeter, B. Shenoy, E.S. Debnam, S.K. Srai, C. Rice-Evans, and U. Hahn Biochem. Biophys. Res. Commun. 277 2000 507
17. H. Lu, X. Meng, and C.S. Yang Drug Metab. Dispos. 31 2003 572 The O-methylation of epicatechin and catechin primarily occurs at the 3′- and 4′-OH via the action of catechol-O-methyltransferase (COMT) and only one OH group is methylated, thus limiting the total number of the epicatechin glucuronides/sulfates that could be formed to ten each (4 non-methylated and 6 methylated forms). For references on the enzymology of methylation of epicatechin and catechin.
18. E.S. Mull, M. Van Zandt, A. Golebiowski, P. Beckett, P.K. Sharma, and H. Schroeter Tetrahedron Lett. 53 2012 1501
19. Zhang, M.; Jagdmann, Jr., G. E.; Van Zandt, M.; Sheeler, R.; Beckett, P.; Schroeter, H. J. Nat. Prod. Published on web on January 28, 2013. http://dx.doi.org/10.1021/np300568m.
20. K.B. Sharpless, W. Amberg, Y.L. Bennani, G.A. Crispino, J. Hartung, K. Jeong, H. Kwong, K. Morikawa, and Z. Wang J. Org. Chem. 57 1992 2768 2771 The absolute stereochemistry of the dihydroxylation products was assigned based on the Sharpless model and confirmed by the final product epicatechins, which show the expected negative specific rotation sign.
21. Romanczyk, L. J., Jr.; Sharma, P. K.; Gou, D.; Gou, Y. PCT Patent Application WO 2007/002877.
22. P.K. Sharma, M. He, L.J. Romanczyk Jr., and H. Schroeter J. Label Compd. Radiopharm. 53 2010 605
23. J.P. Deville, and V. Behar J. Org. Chem. 66 2001 4097
24. C. Prakash, S. Saleh, and I.A. Blair Tetrahedron Lett. 30 1989 19
25. H. Cairns Tetrahedron 28 1972 359
26. T. Furuta, M. Nakayama, H. Suzuki, H. Tajimi, M. Inai, H. Nukaya, T. Wakimoto, and T. Kan Org. Lett. 11 2009 2233
27. J.-L. Luche J. Am. Chem. Soc. 100 1978 2226
28. A.L. Gemal, and J.-L. Luche J. Am. Chem. Soc. 103 1981 5454
29. W.H. Pirkle, D.L. Sikkenga, and M.S. Pavlin J. Org. Chem. 42 1977 384
30. L. Li, and T.H. Chan Org. Lett. 3 2001 739
31. W. Tuckmantel, A.P. Kozikowski, and L.J. Romanczyk Jr. J. Am. Chem. Soc. 121 1999 12073
32. P.K. Sharma, A. Kolchinski, H.A. Shea, J.J. Nair, Y. Gou, L.J. Romanczyk Jr., and H.H. Schmitz Org. Process Res. Dev. 11 2007 422
33. J. Eames, H.J. Mitchell, A. Nelson, P. ÓBrien, S. Warren, and P. Wyatt J. Chem. Soc., Perkin Trans. 1 1999 1095 1103
34. H. Kawamoto J. Wood Chem. Technol. 9 1989 35
35. R.S. Khupse J. Nat. Prod. 70 2007 1507
36. T. Kumazawa, T. Minatogawa, S. Matsuba, S. Sato, and J.-i. Onodera Carbohydr. Res. 329 2000 507
37. M.M. Hossain, T. Tokuoka, K. Yamashita, Y. Kawamura, and M. Tsukayama Synth. Commun. 36 2006 1201
38. I.A. Pearl J. Am. Chem. Soc. 75 1953 2630
39. B. Hegedus Helv. Chim. Acta 46 1963 2604
40. P. Venturella Anal. Chim. 48 1958 706
41. The higher field doublets were further split by the third proton at δ 6.86 ppm with a J = 1.8 Hz.
42. Each H-4 proton was split by H-3 with J = 4.4, 1.7 Hz, respectively.
43. H-6′ was split by H-2′ (J = 1.7 Hz).